The EMBL-EBI Industry Programme
Kazuhisa Tsunoyama and Hiroki Shirai, Astellas Pharma, Inc.
The EMBL-EBI Industry Programme has been an important and vibrant part of EMBL-EBI since 1996, providing regular contact and interaction with key stakeholders and opinion leaders at major global commercial companies and informing them of the institute’s future directions.
The EMBL-EBI Industry Programme is a subscription-based programme for global companies that make significant use of the data and resources provided by EMBL-EBI as a core part of their R&D. Member companies represent most of the top 20 pharmaceutical companies as well as several major agri-food, nutrition and healthcare companies.
The programme is unique, providing regular quarterly strategy meetings, expert-level workshops on topics prioritised by the members, webinars and other activities. It also serves as an interface between industry-focussed initiatives at EMBL-EBI and organisations such as the Innovative Medicines Initiative (IMI), the Pistoia Alliance, the Clinical Data Interchange Standards Consortium (CDISC) and others.
Engaging with industry
In addition to the Industry Programme, EMBL-EBI addresses the needs of industry in a number of ways. Through our participation in the Innovative Medicines Initiative (IMI), we lead projects ranging from drug safety databases to semantic enrichment of scientific literature. We support small and medium-sized enterprise (SMEs) by providing essential data infrastructure and services, enable bioinformatics spin-outs from EMBL and facilitate key pre-competitive and translational projects with our industry partners.
We welcome industry to engage with ELIXIR, the emerging pan-European infrastructure for biological information. Working together, we can empower research and the translation of discoveries into advances in medicine, health, and agriculture for the benefit of society.
Small and medium-sized enterprise
We support SMEs primarily by providing free data, tools and infrastructure. We also organise networking events in collaboration with organisations such as OneNucleus, the UK Trade and Investment agency (UKTI), the InnovateUK Bioinformatics knowledge-transfer network and the ELIXIR SME and Innovation Forum.